Sumitomo Pharma Pink Sheet Forecast - Simple Regression
| SMDPY Stock | 11.45 0.00 0.00% |
Sumitomo Pink Sheet outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Sumitomo Pharma's share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Sumitomo Pharma hype-based prediction, you can estimate the value of Sumitomo Pharma Co from the perspective of Sumitomo Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Sumitomo Pharma Co on the next trading day is expected to be 11.45 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Sumitomo Pharma after-hype prediction price | USD 11.45 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sumitomo |
Sumitomo Pharma Additional Predictive Modules
Most predictive techniques to examine Sumitomo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sumitomo using various technical indicators. When you analyze Sumitomo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sumitomo Pharma Simple Regression Price Forecast For the 29th of January
Given 90 days horizon, the Simple Regression forecasted value of Sumitomo Pharma Co on the next trading day is expected to be 11.45 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Sumitomo Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sumitomo Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sumitomo Pharma Pink Sheet Forecast Pattern
| Backtest Sumitomo Pharma | Sumitomo Pharma Price Prediction | Buy or Sell Advice |
Sumitomo Pharma Forecasted Value
In the context of forecasting Sumitomo Pharma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sumitomo Pharma's downside and upside margins for the forecasting period are 11.45 and 11.45, respectively. We have considered Sumitomo Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Sumitomo Pharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Sumitomo Pharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 54.6049 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Sumitomo Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sumitomo Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sumitomo Pharma After-Hype Price Density Analysis
As far as predicting the price of Sumitomo Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sumitomo Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Sumitomo Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sumitomo Pharma Estimiated After-Hype Price Volatility
In the context of predicting Sumitomo Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sumitomo Pharma's historical news coverage. Sumitomo Pharma's after-hype downside and upside margins for the prediction period are 11.45 and 11.45, respectively. We have considered Sumitomo Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sumitomo Pharma is very steady at this time. Analysis and calculation of next after-hype price of Sumitomo Pharma is based on 3 months time horizon.
Sumitomo Pharma Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sumitomo Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sumitomo Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sumitomo Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.45 | 11.45 | 0.00 |
|
Sumitomo Pharma Hype Timeline
Sumitomo Pharma is at this time traded for 11.45. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sumitomo is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Sumitomo Pharma is about 0.0%, with the expected price after the next announcement by competition of 11.45. The company has price-to-book ratio of 0.68. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sumitomo Pharma had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be within a week. Check out Historical Fundamental Analysis of Sumitomo Pharma to cross-verify your projections.Sumitomo Pharma Related Hype Analysis
Having access to credible news sources related to Sumitomo Pharma's direct competition is more important than ever and may enhance your ability to predict Sumitomo Pharma's future price movements. Getting to know how Sumitomo Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sumitomo Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LVZPF | Livzon Pharmaceutical Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SGFEF | Siegfried Holding AG | 0.19 | 8 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SNPHF | Santen Pharmaceutical Co | 0.00 | 0 per month | 0.00 | 0.16 | 2.35 | 0.00 | 5.68 | |
| ULIHF | The United Laboratories | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HLUBF | H Lundbeck AS | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 11.33 | |
| WLCGF | Welcia Holdings Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CZMWF | Carl Zeiss Meditec | 0.81 | 4 per month | 0.00 | (0.20) | 3.11 | (4.35) | 27.60 | |
| HKMPY | Hikma Pharmaceuticals PLC | 0.00 | 0 per month | 0.00 | (0.08) | 2.79 | (2.80) | 15.46 | |
| SHEZF | Shenzhen Hepalink Pharmaceutical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CZMWY | Carl Zeiss Meditec | 0.81 | 4 per month | 0.00 | (0.25) | 2.76 | (2.96) | 22.31 |
Other Forecasting Options for Sumitomo Pharma
For every potential investor in Sumitomo, whether a beginner or expert, Sumitomo Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sumitomo Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sumitomo. Basic forecasting techniques help filter out the noise by identifying Sumitomo Pharma's price trends.Sumitomo Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sumitomo Pharma pink sheet to make a market-neutral strategy. Peer analysis of Sumitomo Pharma could also be used in its relative valuation, which is a method of valuing Sumitomo Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sumitomo Pharma Market Strength Events
Market strength indicators help investors to evaluate how Sumitomo Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sumitomo Pharma shares will generate the highest return on investment. By undertsting and applying Sumitomo Pharma pink sheet market strength indicators, traders can identify Sumitomo Pharma Co entry and exit signals to maximize returns.
Story Coverage note for Sumitomo Pharma
The number of cover stories for Sumitomo Pharma depends on current market conditions and Sumitomo Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sumitomo Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sumitomo Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Sumitomo Pink Sheet Analysis
When running Sumitomo Pharma's price analysis, check to measure Sumitomo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sumitomo Pharma is operating at the current time. Most of Sumitomo Pharma's value examination focuses on studying past and present price action to predict the probability of Sumitomo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sumitomo Pharma's price. Additionally, you may evaluate how the addition of Sumitomo Pharma to your portfolios can decrease your overall portfolio volatility.